Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Jan-22 | Jan-23 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 1,209 | 1,252 | 1,201 | 1,365 | 1,463 | 1,505 | 2,065 | 1,514 | 1,673 | 2,288 | | 2,288 |
% Growth | NA | 3.5% | -4.1% | 13.6% | 7.2% | 2.9% | 37.2% | -26.7% | 10.5% | 36.8% | | |
| | | | | | | | | | | | |
Cost of Revenue | (815) | (744) | (735) | (923) | (1,017) | (1,039) | (1,248) | (945) | (1,165) | (1,574) | | (1,574) |
Gross Profit | 395 | 508 | 465 | 442 | 447 | 467 | 817 | 569 | 508 | 714 | | 714 |
% Revenue | 32.6% | 40.6% | 38.8% | 32.4% | 30.5% | 31.0% | 39.6% | 37.6% | 30.4% | 31.2% | | 31.2% |
| | | | | | | | | | | | |
Research and Development | (246) | (307) | (342) | (312) | (295) | (284) | (385) | (419) | (488) | (533) | | (533) |
Selling and Marketing | (27) | (44) | (61) | (53) | (36) | (42) | (53) | (42) | (46) | (57) | | (57) |
General and Admin | (295) | (375) | (67) | (65) | (79) | (68) | (76) | (58) | (53) | (58) | | (58) |
Other Inc / (Exp) | 282 | 349 | (27) | 46 | 40 | 97 | 119 | 124 | 45 | 99 | | 99 |
Total Operating Exp | (287) | (378) | (497) | (385) | (370) | (297) | (394) | (395) | (542) | (549) | | (549) |
| | | | | | | | | | | | |
Operating Income | 108 | 131 | (31) | 57 | 77 | 170 | 423 | 174 | (34) | 165 | | 165 |
% Revenue | 8.9% | 10.5% | -2.6% | 4.2% | 5.2% | 11.3% | 20.5% | 11.5% | -2.0% | 7.2% | | 7.2% |
| | | | | | | | | | | | |
Interest Expense | 23 | 20 | 35 | 50 | 55 | 43 | 83 | 46 | 52 | 0 | | 0 |
Pre-tax Income | 131 | 151 | 3 | 107 | 132 | 212 | 506 | 220 | 18 | 165 | | 165 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (3) | (7) | (5) | 1 | 1 | (8) | (11) | (9) | 5 | 2 | | 2 |
Net Income to Company | 128 | 144 | (2) | 108 | 132 | 205 | 494 | 211 | 23 | 167 | | 167 |
% Margin | 10.6% | 11.5% | -0.1% | 7.9% | 9.0% | 13.6% | 23.9% | 13.9% | 1.4% | 7.3% | | 7.3% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 4 | 19 | 10 | 2 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 128 | 149 | 17 | 118 | 135 | 205 | 494 | 211 | 23 | 167 | | 167 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 128 | 149 | 17 | 118 | 135 | 205 | 494 | 211 | 23 | 167 | | 167 |
% Margin | 10.6% | 11.9% | 1.4% | 8.7% | 9.2% | 13.6% | 23.9% | 13.9% | 1.4% | 7.3% | | 7.3% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.23 | 0.24 | 0.03 | 0.19 | 0.22 | 0.33 | 0.79 | 0.34 | 0.04 | 0.26 | | 0.26 |
Diluted EPS (Continuing Ops) | 0.23 | 0.24 | 0.03 | 0.19 | 0.22 | 0.33 | 0.78 | 0.33 | 0.04 | 0.26 | | 0.26 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 547.37 | 615.24 | 658.95 | 623.36 | 623.87 | 627.50 | 625.90 | 620.52 | 574.07 | 641.33 | | 641.33 |
WA Diluted Shares Out. | 547.37 | 615.24 | 658.95 | 623.36 | 623.87 | 627.50 | 633.92 | 639.33 | 574.07 | 641.33 | | 641.33 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 131 | 151 | 3 | 107 | 132 | 212 | 506 | 220 | 18 | 165 | | 165 |
Addback: Net Interest Expense | (23) | (20) | (35) | (50) | (55) | (43) | (83) | (46) | (52) | 0 | | 0 |
Addback: Other Non Operating Expenses, Total | (26) | (37) | 44 | (26) | (1) | 32 | 8 | (6) | (4) | (46) | | (46) |
Addback: Depreciation & Amortization | 65 | 69 | 77 | 76 | 72 | 58 | 79 | 98 | 89 | 116 | | 116 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 13 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | (95) | (82) | (29) | 4 | (14) | | (14) |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | (4) | 0 | (0) | (0) | (0) | 0 | (0) | | (0) |
Addback: Asset Writedown | 0 | 0 | 8 | 11 | 0 | 0 | 0 | 0 | 0 | 30 | | 30 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (19) | (13) | (41) | (54) | (38) | (33) | (39) | (72) | (20) | 0 | | 0 |
Adjusted EBITDA | 128 | 150 | 70 | 83 | 110 | 132 | 389 | 165 | 35 | 251 | | 251 |
% Margin | 10.6% | 12.0% | 5.8% | 6.1% | 7.5% | 8.8% | 18.8% | 10.9% | 2.1% | 11.0% | | 11.0% |
| | | | | | | | | | | | |
Adjusted EBIT | 63 | 81 | (7) | 7 | 38 | 74 | 310 | 67 | (54) | 135 | | 135 |
% Margin | 5.2% | 6.5% | -0.6% | 0.5% | 2.6% | 4.9% | 15.0% | 4.4% | -3.2% | 5.9% | | 5.9% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 128 | 144 | (2) | 108 | 132 | 205 | 494 | 211 | 23 | 167 | | 167 |
Addback: Unusual Items | (19) | (13) | (21) | (24) | (38) | (128) | (120) | (101) | (16) | 16 | | 16 |
Less: Tax Benefit of Unusual Items (26%) | 5 | 3 | 5 | 6 | 10 | 33 | 31 | 26 | 4 | (4) | | (4) |
Adjusted Net Income | 114 | 135 | (17) | 90 | 104 | 110 | 406 | 136 | 11 | 178 | | 178 |
% Margin | 9.4% | 10.8% | -1.4% | 6.6% | 7.1% | 7.3% | 19.6% | 9.0% | 0.7% | 7.8% | | 7.8% |